View:
United States securities and exchange commission logo
May 1, 2023
Daniel P. Gold
President and Chief Executive Officer
MEI Pharma, Inc.
11455 El Camino Real, Suite 250
San Diego, California 92130
Re: MEI Pharma, Inc.
Registration
Statement on Form S-4
Filed April 28,
2023
File No. 333-271481
Dear Daniel P. Gold:
This is to advise you that we have not reviewed and will not
review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for
acceleration. We remind you
that the company and its management are responsible for the accuracy and
adequacy of their
disclosures, notwithstanding any review, comments, action or absence of
action by the staff.
Please contact Joshua
Gorsky at 202-551-7836 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Steven Navarro